Pipeline

ABL202

HomePipelineABL202

  • Pipeline
    ABL202
  • Program Target
    ROR1
  • Disease Indication
    CLL/TNBC
  • Development Stage
    Early development
Summary
ABL202 is an ADC comprised of a ROR1-specific antibody and a highly potent cytotoxic payload, and can deliver the payload to ROR1-expressing cells. ROR1 is a membrane protein whose expression is specifically elevated in cancers including chronic lymphocytic leukemia, breast cancer, and lung cancer. It is suspected that ROR1 is involved in tumor metastasis. ABL202 acts on ROR1 expressing cells and kill the target expression cells.
ABL202
좌우스크롤 ABL202